Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review
- Supplementary File 1:
PDF-Document (PDF, 291 KiB)
Greco, A.; Safi, D.; Swami, U.; Ginader, T.; Milhem, M.; Zakharia, Y. Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review. Cancers 2019, 11, 1950. https://doi.org/10.3390/cancers11121950
Greco A, Safi D, Swami U, Ginader T, Milhem M, Zakharia Y. Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review. Cancers. 2019; 11(12):1950. https://doi.org/10.3390/cancers11121950
Chicago/Turabian StyleGreco, Austin, Danish Safi, Umang Swami, Tim Ginader, Mohammed Milhem, and Yousef Zakharia. 2019. "Efficacy and Adverse Events in Metastatic Melanoma Patients Treated with Combination BRAF Plus MEK Inhibitors Versus BRAF Inhibitors: A Systematic Review" Cancers 11, no. 12: 1950. https://doi.org/10.3390/cancers11121950